|
ZSCAN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.761600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.679400E-01 |
| Normal-vs-Stage2 |
3.225800E-02 |
| Normal-vs-Stage3 |
2.644200E-03 |
| Normal-vs-Stage4 |
1.097780E-01 |
| Stage1-vs-Stage2 |
3.876100E-02 |
| Stage1-vs-Stage3 |
2.060200E-03 |
| Stage1-vs-Stage4 |
1.500350E-01 |
| Stage2-vs-Stage3 |
8.436600E-01 |
| Stage2-vs-Stage4 |
7.481200E-01 |
| Stage3-vs-Stage4 |
5.841000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.827800E-02 |
| Normal-vs-AfricanAmerican |
6.030200E-01 |
| Normal-vs-Asian |
9.496000E-01 |
| Caucasian-vs-AfricanAmerican |
4.115600E-01 |
| Caucasian-vs-Asian |
6.822000E-01 |
| AfricanAmerican-vs-Asian |
7.735800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.503490E-03 |
| Normal-vs-Female |
5.877200E-01 |
| Male-vs-Female |
9.61349999999417E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.618630E-01 |
| Normal-vs-Age(41-60Yrs) |
2.135400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.626100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.279000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.627400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.795200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.102600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.003400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.267200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.698580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.632600E-01 |
| Normal-vs-Grade 2 |
8.774600E-01 |
| Normal-vs-Grade 3 |
8.389700E-02 |
| Normal-vs-Grade 4 |
3.54830000004469E-06 |
| Grade 1-vs-Grade 2 |
7.363200E-01 |
| Grade 1-vs-Grade 3 |
1.517230E-01 |
| Grade 1-vs-Grade 4 |
4.808600E-04 |
| Grade 2-vs-Grade 3 |
7.839700E-02 |
| Grade 2-vs-Grade 4 |
3.99829999997436E-06 |
| Grade 3-vs-Grade 4 |
8.604100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.874200E-02 |
| Normal-vs-ccB subtype |
3.6299000027995E-08 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.880620E-01 |
| Normal-vs-N1 |
1.417640E-03 |
| N0-vs-N1 |
6.073900E-02 |
|
|
